Houston innovator: 3 reasons you should incorporate estate planning to your company benefits

guest column

Why you should be offering your employees estate and legacy planning tools. Photo courtesy of The Postage

As priorities for employees have shifted as part of the Great Resignation the need for non-traditional benefits has continued to arise. Employees are expecting their personal and family wellness to be at the core of what their employers are offering. This is a big consideration when deciding to stay or leave a company. While HR professionals and employers are realizing they need to re-evaluate their benefits and how they keep top talent, there’s one key benefit that is typically missed that is a life necessity for all, estate and legacy planning.

Given today’s uber competitive talent market, there’s an opportunity for companies to embrace new benefits that go beyond the typical and support vital needs, such as financial wellness and estate planning. Taking the next step by providing and connecting employees with the right resources can make all the difference. Estate and legacy planning goes beyond creating a will, it’s about end to end care of life and legacy. It helps transition wealth and wisdom across generations. It handles your affairs, finances, your digital assets, protects your children and pets, and ensures your wishes are carried out if you are temporarily unavailable or permanently incapable of handling them. It’s as critical and as necessary as insurance yet is not typically included as a key employee benefit.

Why should you add estate and legacy planning as part of your employee benefits? Here’s the top three reasons to consider:

1. Create value for your employees and their families

Financial wellness and security are the utmost important for employees. In fact, it’s one of the most-valued benefits, based on a recent survey Morgan Stanley found that 90 percent of employees want their company to prioritize financial benefits. Are you going to be one of the 95 percent of HR executives that plan to do so? If so, there are multiple ways that a company can help its employees to build wealth and protect their financial security through traditional benefits such as retirement savings plans, health insurance, voluntary life, and disability insurance, and more. But additional benefits like estate and legacy planning should be a part of this assortment of benefits that support protecting employees and their families’ finances - by helping them build and protect their financial and personal legacies.

Employers can show that they value and support their employee’s financial success and security by providing tools and resources that make it simple to handle these historically daunting tasks and keep them organized throughout life, which allows employees to have peace of mind for their families’ future, financial and beyond.

2. Stand out among your competitors

Most employers do not provide legacy and estate planning services. Only 12 percent of employers provide these types of benefits, yet over 72 percent of those who are not offered estate planning services by their employer, would be interested in using them if offered. That’s a huge percentage of your employee population that would benefit from this service while differentiating you from other employers and provide an opportunity for your company to show just how much you value your employees’ futures.

3. Show you care about your employees

More people have begun to self-reflect on what is truly important to them as a part of the Great Resignation. Now, employee desires have evolved beyond a high salary with decent benefits. Employees want to feel valued beyond the work they do, and even further than that, they need an environment where their career, their loved ones, and their own being is supported. These psychological needs are translating into demands for companies to provide more thoughtful employee benefits packages.

A study conducted by Morgan Stanley shows how perceptions of employees and HR executives alike have transformed, with 9 in 10 HR executives saying their company needs to do a better job helping employees understand how to maximize their financial benefits. Proving to your employees that you care about them beyond the ‘now’–beyond simply providing short-term benefits that exclusively affect them in the present day–leverages your company’s commitment to caring for your workers.

For people that struggle with organizing their property and wealth, estate planning can help visualize their total net worth. However, benefits that not only anticipate employees’ future financial needs but also organize their family network will drive continual engagement within your company and prove genuine care for your workers. For example, The Postage helps people plan their legacy. On top of estate planning, customers also have the ability to store and document important life events and memories, or even utilize our message planning feature where they can send timely notes to their family at a future date.

Employees want to feel valued beyond their work and taking the steps to help them build physical and financial legacies for both themselves and their loved ones will put your company one step ahead of everyone else. It is time for estate planning to join the conversation for employee benefits packages and helping employees proactively plan their future could be the cornerstone of attracting and retaining diverse talent.

------

Emily Cisek is the founder and CEO of The Postage, a tech-enabled, easy-to-use estate planning tool.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Intuitive Machines forms partnership with Italian companies for lunar exploration services

to the moon

Houston-based space technology, infrastructure and services company Intuitive Machines has forged a partnership with two Italian companies to offer infrastructure, communication and navigation services for exploration of the moon.

Intuitive Machines’ agreement with the two companies, Leonardo and Telespazio, paves the way for collaboration on satellite services for NASA, a customer of Intuitive Machines, and the European Space Agency, a customer of Leonardo and Telespazio. Leonardo, an aerospace, defense and security company, is the majority owner of Telespazio, a provider of satellite technology and services.

“Resilient, secure, and scalable space infrastructure and space data networks are vital to customers who want to push farther on the lunar surface and beyond to Mars,” Steve Altemus, co-founder and CEO of Intuitive Machine, said in a news release.

Massimo Claudio Comparini, managing director of Leonardo’s space division, added that the partnership with Intuitive Machines is a big step toward enabling human and robotic missions from the U.S., Europe and other places “to access a robust communications network and high-precision navigation services while operating in the lunar environment.”

Intuitive Machines recently expanded its Houston Spaceport facilities to ramp up in-house production of satellites. The company’s first satellite will launch with its upcoming IM‑3 lunar mission.

Intuitive Machines says it ultimately wants to establish a “center of space excellence” at Houston Spaceport to support missions to the moon, Mars and the region between Earth and the moon.

Houston hospitals win $50M grant for ibogaine addiction treatment research

ibogaine funding

The Texas Health and Human Services Commission has awarded $50 million to UTHealth Houston in collaboration with The University of Texas Medical Branch at Galveston (UTMB Health) to co-lead a multicenter research trial to evaluate the effect of ibogaine, a powerful psychoactive compound, on patients suffering from addiction, traumatic brain injury and other behavioral health conditions.

The funding will establish a two-year initiative—known as Ibogaine Medicine for PTSD, Addiction, and Cognitive Trauma (IMPACT)—and a consortium of Texas health institutions focused on clinical trials and working toward potential FDA-approved treatments.

The consoritum will also include Texas Tech University, Texas Tech University Health Sciences Center El Paso, The University of Texas at Austin, The University of Texas Health Science Center at San Antonio, The University of Texas at Tyler, The University of Texas Rio Grande Valley, Texas A&M University, The University of North Texas Health Science Center, Baylor College of Medicine and JPS Health Network in Dallas.

Ibogaine is a plant-based, psychoactive substance derived from the iboga shrub. Research suggests that the substance could be used for potential treatment for patients with traumatic brain injuries, which is a leading cause of post-traumatic stress disorders. Ibogaine has also shown potential as a treatment for addiction and other neurological conditions.

UTHealth and partners will focus on ways that ibogaine can treat addiction and associated conditions. Meanwhile, UT Austin and Baylor College of Medicine will concentrate on using it to treat traumatic brain injury, especially in veterans, according to a news release from the institutions.

The consortium will also support drug developers and teaching hospitals to conduct FDA-approved clinical trials. The Texas Health and Human Services Commission will oversee the grant program.

“This landmark clinical trial reflects our unwavering commitment to advancing research that improves lives and delivers the highest standards of care,” Dr. Melina Kibbe, UTHealth Houston president and the Alkek-Williams Distinguished Chair, said in the news release. “By joining forces with outstanding partners across our state, we are building on Texas’ tradition of innovation to ensure patients struggling with addiction and behavioral health conditions have access to the best possible outcomes. Together, we are shaping discoveries that will serve Texans and set a model for the nation.”

The consortium was authorized by the passage of Senate Bill 2308. The bill provides $50 million in state-matching funds for an ibogaine clinical trial managed by a public university in partnership with a drug company and a hospital.

“This is the first major step towards the legislature’s goal of obtaining FDA approval through clinical trials of ibogaine — a potential breakthrough medication that has brought thousands of America’s war-fighters back from the darkest parts of depression, anxiety, PTSD, and chronic addiction,” Texas Rep. Cody Harris added in the release. “I am excited to walk alongside UTHealth Houston and UTMB as these stellar institutions lead the nation in a first-of-its-kind clinical trial in the U.S.”

Recently, the University of Houston also received a $2.6 million gift from the estate of Dr. William A. Gibson to support and expand its opioid addiction research, which includes the development of a fentanyl vaccine that could block the drug's ability to enter the brain. Read more here.

Tesla no longer world's biggest EV maker as sales fall for second year

Tesla Talk

Tesla lost its crown as the world’s bestselling electric vehicle maker as a customer revolt over Elon Musk’s right-wing politics, expiring U.S. tax breaks for buyers and stiff overseas competition pushed sales down for a second year in a row.

Tesla said that it delivered 1.64 million vehicles in 2025, down 9% from a year earlier.

Chinese rival BYD, which sold 2.26 million vehicles last year, is now the biggest EV maker.

It's a stunning reversal for a car company whose rise once seemed unstoppable as it overtook traditional automakers with far more resources and helped make Musk the world's richest man. The sales drop came despite President Donald Trump's marketing effort early last year when he called a press conference to praise Musk as a “patriot” in front of Teslas lined up on the White House driveway, then announced he would be buying one, bucking presidential precedent to not endorse private company products.

For the fourth quarter, Tesla sales totaled 418,227, falling short of even the much reduced 440,000 target that analysts recently polled by FactSet had expected. Sales were hit hard by the expiration of a $7,500 tax credit for electric vehicle purchases that was phased out by the Trump administration at the end of September.

Tesla stock fell 2.6% to $438.07 on Friday.

Even with multiple issues buffeting the company, investors are betting that Tesla CEO Musk can deliver on his ambitions to make Tesla a leader in robotaxi services and get consumers to embrace humanoid robots that can perform basic tasks in homes and offices. Reflecting that optimism, the stock finished 2025 with a gain of approximately 11%.

The latest quarter was the first with sales of stripped-down versions of the Model Y and Model 3 that Musk unveiled in early October as part of an effort to revive sales. The new Model Y costs just under $40,000 while customers can buy the cheaper Model 3 for under $37,000. Those versions are expected to help Tesla compete with Chinese models in Europe and Asia.

For fourth-quarter earnings coming out in late January, analysts are expecting the company to post a 3% drop in sales and a nearly 40% drop in earnings per share, according to FactSet. Analysts expect the downward trend in sales and profits to eventually reverse itself as 2026 rolls along.

Musk said earlier last year that a “major rebound” in sales was underway, but investors were unruffled when that didn't pan out, choosing instead to focus on Musk's pivot to different parts of business. He has has been saying the future of the company lies with its driverless robotaxis service, its energy storage business and building robots for the home and factory — and much less with car sales.

Tesla started rolling out its robotaxi service in Austin in June, first with safety monitors in the cars to take over in case of trouble, then testing without them. The company hopes to roll out the service in several cities this year.

To do that successfully, it needs to take on rival Waymo, which has been operating autonomous taxis for years and has far more customers. It also will also have to contend with regulatory challenges. The company is under several federal safety investigations and other probes. In California, Tesla is at risk of temporarily losing its license to sell cars in the state after a judge there ruled it had misled customers about their safety.

“Regulatory is going to be a big issue,” said Wedbush Securities analyst Dan Ives, a well-known bull on the stock. “We're dealing with people's lives.”

Still, Ives said he expects Tesla's autonomous offerings will soon overcome any setbacks.

Musk has said he hopes software updates to his cars will enable hundreds of thousands of Tesla vehicles to operate autonomously with zero human intervention by the end of this year. The company is also planning to begin production of its AI-powered Cybercab with no steering wheel or pedals in 2026.

To keep Musk focused on the company, Tesla’s directors awarded Musk a potentially enormous new pay package that shareholders backed at the annual meeting in November.

Musk scored another huge windfall two weeks ago when the Delaware Supreme Court reversed a decision that deprived him of a $55 billion pay package that Tesla doled out in 2018.

Musk could become the world's first trillionaire later this year when he sells shares of his rocket company SpaceX to the public for the first time in what analysts expect would be a blockbuster initial public offering.

View All Listings